A

Allogene (ALLO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Allogene (ALLO)

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more

  • USD5.00
  • USD5.16
  • USD4.88
  • USD17.49
  • -18.90%
  • 0M
  • 1.39M
  • 2.13M
  • 725M
  • 4.91
  • -49.40%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.